349 related items for PubMed ID: 29913001
1. Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial.
Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F.
JAMA Pediatr; 2018 Aug 01; 172(8):757-764. PubMed ID: 29913001
[Abstract] [Full Text] [Related]
2. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
Health Technol Assess; 2019 May 01; 23(26):1-108. PubMed ID: 31156083
[Abstract] [Full Text] [Related]
3. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 01; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
4. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 01; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
5. Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.
Sinha A, Bagga A, Gulati A, Hari P.
Pediatr Nephrol; 2012 Feb 01; 27(2):235-41. PubMed ID: 21922213
[Abstract] [Full Text] [Related]
6. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May 01; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
7. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P, Bonanni A, Ghiggeri GM.
BMJ Open; 2017 Mar 17; 7(3):e013319. PubMed ID: 28314744
[Abstract] [Full Text] [Related]
8. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov 17; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
9. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug 17; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
10. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
11. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
Kidney Int; 2019 Jan 04; 95(1):210-218. PubMed ID: 30497684
[Abstract] [Full Text] [Related]
12. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2001 Jan 04; (2):CD001533. PubMed ID: 11405997
[Abstract] [Full Text] [Related]
13. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2000 Jan 04; (4):CD001533. PubMed ID: 11034723
[Abstract] [Full Text] [Related]
14. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul 04; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
15. Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea.
Ahn YH, Kim SH, Han KH, Choi HJ, Cho H, Lee JW, Shin JI, Cho MH, Lee JH, Park YS, Ha IS, Cheong HI, Kim SY, Lee SJ, Kang HG.
Medicine (Baltimore); 2018 Nov 04; 97(46):e13157. PubMed ID: 30431588
[Abstract] [Full Text] [Related]
16. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A.
Nephrol Dial Transplant; 2015 Jan 04; 30(1):96-106. PubMed ID: 25121488
[Abstract] [Full Text] [Related]
17. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.
Kidney Int; 2013 Nov 04; 84(5):1025-33. PubMed ID: 23739238
[Abstract] [Full Text] [Related]
18. Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome.
Basu B, Erdmann S, Sander A, Mahapatra TKS, Meis J, Schaefer F.
Kidney Int Rep; 2023 Aug 04; 8(8):1575-1584. PubMed ID: 37547526
[Abstract] [Full Text] [Related]
19. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 04; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
20. Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T.
J Pediatr; 2018 Jun 04; 197():191-197.e1. PubMed ID: 29680473
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
